UNSPSC 51284110: Cefpimizole

This classification denotes a cephalosporin antibiotic with the molecular formula C28H26N6O10S2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 24S58UHU7N, chemically known as 1-(((6r,7r)-2-carboxy-7-((r)-2-(5-carboxyimidazole-4-carboxamido)-2-phenylacetamido)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-en-3-yl)methyl)-4-(2-sulfoethyl)pyridinium hydroxide, inner salt but generally known as cefpimizole, which bears US NIH Compound Identifier 68597.

UNSPSC 51284110 Cefpimizole is a Commodity code that in recent state and local solicitations does not align with actual buying activity — the code nominally describes a specific antibiotic pharmaceutical, but the recent opportunities tagged under it address naloxone, drug deactivation systems, direct-to-manufacturer prescription programs, generic multi-source pharmaceuticals, and emergency medical supplies, none of which match cefpimizole's scope. State and local governments procuring under this code appear to be sourcing through broad pharmaceutical and OTC product cooperative purchasing agreements rather than seeking cefpimizole specifically. The issuing bodies include state health agencies, county health departments, municipal fire departments, and cooperative purchasing alliances spanning multiple states and jurisdictions, reflecting the distributed nature of healthcare and emergency response procurement across government.

Geographic activity appears concentrated in Florida, Texas, and Minnesota, with interstate reach through cooperative purchasing vehicles. Recent representative opportunities include Seminole County, Florida's IFB 60459723LAS (due July 26, 2023) for naloxone and drug deactivation systems with quarterly deliveries to community health facilities; the Texas Health and Human Services Commission's RFI HHS0017013 (due April 3, 2026) for direct-to-manufacturer prescription capabilities; the City of Tampa's ITB 26P00145 (due March 13, 2026) for medical and first aid supplies to the Fire Department Rescue Division, estimated at $700,000, designated as a sheltered market for certified Small Local Business Enterprises with a 5 percent bid discount; and the Minnesota Multistate Cooperative Purchasing Alliance's RFP S1070000015802 (due March 26, 2026) for generic multi-source pharmaceuticals and OTC products serving state and local facilities across participating states. The mismatch between the code's nominal scope and the actual procurement activity suggests either miscoding by issuing bodies or that cefpimizole itself sees minimal direct solicitation at the state and local level.